Timepoint | Study period | |||
---|---|---|---|---|
Enrolment | Baseline | Treatment phase | ||
− 1 week | 0 week | 1 week | 2 weeks | |
Enrolment | ||||
Eligibility screen | × | |||
Informed consent | × | |||
Medical history | × | |||
Merger disease | × | |||
Randomization | × | |||
Interventions | ||||
Experimental group | × | × | × | |
Control group | × | × | × | |
Assessments | ||||
VAS | × | × | × | × |
ODI | × | × | × | |
sEMG | × | × | × | |
Safety evaluation | × | × | × | |
Adverse events | × | × | × |